Retina IQ
Advanced AI for retinal disease screening — built to close the diabetic-eye-care gap.
Retina IQ analyzes retinal images in seconds with specialist-level precision to detect Age-related Macular Degeneration (AMD), Diabetic Retinopathy, and Glaucoma. By delivering instant automated analysis and comprehensive clinical reports, Retina IQ enables healthcare providers to identify sight-threatening conditions earlier, expand screening capacity, and improve eye-care delivery efficiency across diverse clinical settings.
Intelligent Capabilities
Instant Analysis for Any Retinal Image
Accelerate case review and reporting with instant AI analysis of retinal images. Process images from any standard fundus camera or imaging system, eliminating specialist-availability bottlenecks.
Comprehensive Finding Detection
Identify microaneurysms and hemorrhages that indicate early disease. Recognize neovascularization that signals proliferative retinopathy, and flag subtle changes that might escape human detection.
Expert-Grade Severity Assessment
Clear severity classification from none to proliferative DR, with risk-level stratification to prioritize follow-up care — enabling consistent grading across all screening locations.
Intelligent Reporting System
Generate comprehensive, customizable reports instantly. Reports include visual markers highlighting detected findings and patient-friendly educational materials for clinical conversations.
Expanded Screening Capabilities
Enable screening in primary care without specialist staffing. Expand access through community clinics reaching underserved populations and mobile screening units operating in remote areas.
Seamless Workflow Integration
Deploy as cloud-based solution or on-premise according to practice needs. Integrate directly with your existing EMR and imaging systems, eliminating manual transfers with automatic result documentation.
Built to bring eye screening closer to patients.
Primary Care and Diabetes Clinics
Eye screening during routine diabetes visits.
Screening Programs
Support for regional and national screening programs.
Eye Clinics and Ophthalmologists
Screened patients arrive with images and findings ready to review.
The details
Imaging modalities supported+
Color fundus photography (CFP) from major standard cameras and mobile fundus devices. OCT-based modalities are on the roadmap; speak to your account manager about current availability.
Conditions covered+
Diabetic retinopathy (severity grading from none to proliferative), age-related macular degeneration (AMD), and glaucoma indicators. Additional conditions are added as supporting evidence and regional validation grow.
Performance envelope+
Per-image analysis in seconds at 1× hardware. Batch ingestion and processing supports community-screening volume.
Deployment model+
Cloud, on-premise, or hybrid. Community-screening and mobile-clinic deployments are typically cloud-hosted for operational simplicity.
Integration interfaces+
DICOM ingestion where supported, REST APIs for non-DICOM cameras, HL7 v2.x for results into the EMR, and printable patient-friendly PDF reports.
Security posture+
AES-256 at rest, TLS 1.3 in transit, RBAC, full audit logging. Saudi-region cloud deployments align with PDPL data residency.
Clinical scope+
Retina IQ is an AI-assisted screening and grading aid. It does not replace ophthalmologist interpretation; positive findings remain subject to specialist follow-up.
Fits into the systems you already run
Fundus Camera
Works with any standard fundus or mobile fundus camera.
EMR
HL7-based result documentation into the patient record.
Primary Care
Enable screening in primary-care settings without on-site specialists.
On-premise
Self-hosted deployment for hospitals requiring full-tenant isolation.
Cloud
Saudi-region cloud deployment, PDPL-aligned.
Frequently Asked Questions
Retina IQ is being developed against SFDA medical-device requirements within ThakaaMed's ISO 13485:2016 quality management system and an IEC 62304-compliant software lifecycle. PDPL alignment is built in for Saudi-region deployments. Final regulatory status will be confirmed at general availability.
Read more
The Economics of AI in Diabetic Retinopathy Screening
Diabetic retinopathy (DR) remains a leading cause of preventable blindness worldwide. Despite established screening guidelines, healthcare systems struggle to provide timely, accessible screening to growing diabetic…
Closing the Diabetic Eye Screening Gap with AI Technology
Despite clear clinical guidelines recommending annual eye examinations for diabetic patients, screening compliance remains alarmingly low worldwide. Estimates suggest that between 40-60% of diabetic patients do not…
AI and Ophthalmologists: The Future of Collaborative Eye Care
The integration of artificial intelligence into ophthalmology has sparked both excitement and concern among eye care professionals. While some have expressed fears about AI replacing clinical judgment, the reality…
Built on a clinical-grade foundation
Medical-device quality management system
Information security management system in implementation
Developed under an IEC 62304-compliant software lifecycle
On-premise or Saudi-region deployment — customer's choice
Encryption at rest; TLS 1.3 in transit
Saudi Personal Data Protection Law compliance
Clinical data exchange on the FHIR R4 standard
Native DICOM imaging interoperability